Acutus Medical is an arrhythmia management company. Co. designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Co.'s product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters (available only in its European markets), mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Co.'s primary product is its AcQMap imaging and mapping system, which provides a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias with unmatched speed and precision. The AFIB stock yearly return is shown above.
The yearly return on the AFIB stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the AFIB annual return calculation with any dividends reinvested as applicable (on ex-dates).
|